Quetiapine (Seroquel) Dosing Guidelines
The recommended initial dose of quetiapine depends on the indication, with schizophrenia requiring 25 mg twice daily on day 1, titrated to 300-400 mg by day 4, with a maximum dose of 750 mg/day for adults. 1
Dosing by Indication
Schizophrenia
Adults:
- Initial: Day 1: 25 mg twice daily
- Titration: Increase in increments of 25-50 mg divided two or three times daily on Days 2 and 3
- Target: 300-400 mg by Day 4
- Recommended range: 150-750 mg/day
- Maximum: 750 mg/day 1
Adolescents (13-17 years):
- Initial: Day 1: 25 mg twice daily
- Titration: Day 2: 100 mg/day; Day 3: 200 mg/day; Day 4: 300 mg/day; Day 5: 400 mg/day
- Recommended range: 400-800 mg/day
- Maximum: 800 mg/day 1
Bipolar Mania
Adults (monotherapy or adjunct):
- Initial: Day 1: 100 mg/day in divided doses
- Titration: Day 2: 200 mg/day; Day 3: 300 mg/day; Day 4: 400 mg/day
- Further adjustments up to 800 mg/day by Day 6 in increments ≤200 mg/day
- Recommended range: 400-800 mg/day
- Maximum: 800 mg/day 1
Children/Adolescents (10-17 years):
- Initial: Day 1: 25 mg twice daily
- Titration: Day 2: 100 mg/day; Day 3: 200 mg/day; Day 4: 300 mg/day; Day 5: 400 mg/day
- Recommended range: 400-600 mg/day
- Maximum: 600 mg/day 1
Bipolar Depression
- Adults:
- Initial: Day 1: 50 mg at bedtime
- Titration: Day 2: 100 mg; Day 3: 200 mg; Day 4: 300 mg
- Recommended dose: 300 mg/day
- Maximum: 300 mg/day 1
Administration Considerations
- Can be taken with or without food 1
- Dosing frequency:
Special Populations
Elderly Patients
- Start at lower dose: 50 mg/day
- Titrate more slowly in increments of 50 mg/day
- Monitor closely for hypotensive reactions 1
Hepatically Impaired Patients
- Start at 25 mg/day
- Increase daily in increments of 25-50 mg/day based on clinical response and tolerability 1
Rapid Dose Escalation
- Research suggests that escalation to 400 mg/day can be safely accomplished in 2-3 days rather than the standard 5-day titration in acutely ill hospitalized patients 3
- However, standard titration is preferred for outpatients and those at risk for hypotension
Dose-Response Relationship
- Fixed-dose studies suggest that 150-450 mg/day is more effective than placebo and no less effective than 600-750 mg/day for most patients with schizophrenia 4
- Doses of 400 mg/day or higher should be used in patients who do not fully respond to lower doses 5
- Extended-release formulation studies suggest 600-800 mg/day may be more effective than 400 mg/day 4
Maintenance Treatment
- For schizophrenia and bipolar disorder maintenance: 400-800 mg/day
- Patients should be periodically reassessed to determine the need for continued maintenance treatment 1
Common Pitfalls and Caveats
- Underdosing: Doses below 150 mg/day are generally subtherapeutic for most indications
- Excessive sedation: May require dividing the dose or administering a larger portion at bedtime
- Orthostatic hypotension: Monitor blood pressure during initial titration, especially in elderly
- Metabolic effects: Monitor weight, blood glucose, and lipid profiles regularly
- Discontinuation: Avoid abrupt discontinuation; taper gradually over 1-2 weeks
Monitoring Recommendations
- Baseline: Complete blood count, metabolic panel, lipid profile, weight, blood pressure
- Follow-up: Weight at each visit; metabolic parameters at 3 months and then annually
- Efficacy assessment: Allow 2-4 weeks at therapeutic dose before determining response
Quetiapine has the advantage of placebo-level incidence of extrapyramidal symptoms (EPS) and minimal effect on prolactin levels at all doses, making it well-tolerated across its dosing range 5.